Ophthalmic Disease Prevalence Models

Market Scope’s ophthalmic disease models offer extensive country-level prevalence data and five-year forecasts by age group for all countries with a population over a million.

These proprietary models take into consideration the latest clinical research and demographic projections on a global scale and can be customized by geography and disease category to meet clients’ diverse needs. Disease models are often used to evaluate target markets for clinical-stage and commercial-stage products and gain insights into the volume and demographics of diseased populations.

Clinical Studies Researched

Ophthalmic Diseases/Conditions Modeled

Countries Forecasted

Diseases Modeled

  • Angle-closure glaucoma
  • Open-angle glaucoma
  • Secondary glaucoma
  • Ocular hypertension
  • Early AMD
  • Late AMD
  • Wet AMD
  • Geographic Atrophy
  • Retinal Vein Occlusion
  • Diabetic Retinopathy
Dry Eye
Dry Eye
  • Preclinical dry eye
  • Dry eye
  • Those at risk for dry eye
  • Meibomian gland dysfunction with dry eye
  • Sjogren's with dry eye
  • Seven others
Refractive Error
Refractive Error
  • Myopia (by diopter)
  • Hyperopia (by diopter)
  • Presbyopia
  • Plano-presbyopes
  • Astigmatism
  • Keratoconus
  • Other Ectasias
  • Fuchs' Dystrophy
  • Other Dystrophies
  • Acquired & Infectious
  • Congenital
  • Other Keratitis

Use cases

  • Evaluation of target markets
  • Country-level market sizing and potential
  • Clinical trial planning
  • Product and company valuation
  • Allocation of resources

Available Models

2023 Dry Eye Disease Model, December, 2023
2023 Refractive Error Model, December, 2023
2023 Corneal Disease Model, December, 2023
2023 Retinal Disease Model, September, 2023
2023 Glaucoma Disease Model, March, 2023

Learn More

Contact us using the button below to request more information about these models, request a sample, or schedule a time to discuss live with our team.

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more